These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1057 related articles for article (PubMed ID: 24215318)
1. The interaction between signal regulatory protein alpha (SIRPα) and CD47: structure, function, and therapeutic target. Barclay AN; Van den Berg TK Annu Rev Immunol; 2014; 32():25-50. PubMed ID: 24215318 [TBL] [Abstract][Full Text] [Related]
2. The CD47-SIRPα signalling system: its physiological roles and therapeutic application. Murata Y; Kotani T; Ohnishi H; Matozaki T J Biochem; 2014 Jun; 155(6):335-44. PubMed ID: 24627525 [TBL] [Abstract][Full Text] [Related]
3. Soluble extracellular domains of human SIRPα and CD47 expressed in Escherichia coli enhances the phagocytosis of leukemia cells by macrophages in vitro. Lin Y; Yan XQ; Yang F; Yang XW; Jiang X; Zhao XC; Zhu BK; Liu L; Qin HY; Liang YM; Han H Protein Expr Purif; 2012 Sep; 85(1):109-16. PubMed ID: 22813925 [TBL] [Abstract][Full Text] [Related]
4. Functional elements on SIRPalpha IgV domain mediate cell surface binding to CD47. Liu Y; Tong Q; Zhou Y; Lee HW; Yang JJ; Bühring HJ; Chen YT; Ha B; Chen CX; Yang Y; Zen K J Mol Biol; 2007 Jan; 365(3):680-93. PubMed ID: 17070842 [TBL] [Abstract][Full Text] [Related]
5. "Velcro" engineering of high affinity CD47 ectodomain as signal regulatory protein α (SIRPα) antagonists that enhance antibody-dependent cellular phagocytosis. Ho CC; Guo N; Sockolosky JT; Ring AM; Weiskopf K; Özkan E; Mori Y; Weissman IL; Garcia KC J Biol Chem; 2015 May; 290(20):12650-63. PubMed ID: 25837251 [TBL] [Abstract][Full Text] [Related]
6. Loss of Cell Surface CD47 Clustering Formation and Binding Avidity to SIRPα Facilitate Apoptotic Cell Clearance by Macrophages. Lv Z; Bian Z; Shi L; Niu S; Ha B; Tremblay A; Li L; Zhang X; Paluszynski J; Liu M; Zen K; Liu Y J Immunol; 2015 Jul; 195(2):661-71. PubMed ID: 26085683 [TBL] [Abstract][Full Text] [Related]
7. Absence of CD47 in vivo influences thymic dendritic cell subset proportions but not negative selection of thymocytes. Guimont-Desrochers F; Beauchamp C; Chabot-Roy G; Dugas V; Hillhouse EE; Dusseault J; Langlois G; Gautier-Ethier P; Darwiche J; Sarfati M; Lesage S Int Immunol; 2009 Feb; 21(2):167-77. PubMed ID: 19147837 [TBL] [Abstract][Full Text] [Related]
8. Role for CD47-SIRPalpha signaling in xenograft rejection by macrophages. Ide K; Wang H; Tahara H; Liu J; Wang X; Asahara T; Sykes M; Yang YG; Ohdan H Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5062-6. PubMed ID: 17360380 [TBL] [Abstract][Full Text] [Related]
9. The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer. Matlung HL; Szilagyi K; Barclay NA; van den Berg TK Immunol Rev; 2017 Mar; 276(1):145-164. PubMed ID: 28258703 [TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in the human inhibitory signal-regulatory protein α do not affect binding to its ligand CD47. Hatherley D; Lea SM; Johnson S; Barclay AN J Biol Chem; 2014 Apr; 289(14):10024-8. PubMed ID: 24550402 [TBL] [Abstract][Full Text] [Related]
11. Autoimmune animal models in the analysis of the CD47-SIRPα signaling pathway. Murata Y; Saito Y; Kaneko T; Kotani T; Kaneko Y; Ohnishi H; Matozaki T Methods; 2014 Jan; 65(2):254-9. PubMed ID: 24091004 [TBL] [Abstract][Full Text] [Related]
12. Functions and molecular mechanisms of the CD47-SIRPalpha signalling pathway. Matozaki T; Murata Y; Okazawa H; Ohnishi H Trends Cell Biol; 2009 Feb; 19(2):72-80. PubMed ID: 19144521 [TBL] [Abstract][Full Text] [Related]
13. The regulation of CD47-SIRPα signaling axis by microRNAs in combination with conventional cytotoxic drugs together with the help of nano-delivery: a choice for therapy? Beizavi Z; Gheibihayat SM; Moghadasian H; Zare H; Yeganeh BS; Askari H; Vakili S; Tajbakhsh A; Savardashtaki A Mol Biol Rep; 2021 Jul; 48(7):5707-5722. PubMed ID: 34275112 [TBL] [Abstract][Full Text] [Related]
14. Structural insight into the specific interaction between murine SHPS-1/SIRP alpha and its ligand CD47. Nakaishi A; Hirose M; Yoshimura M; Oneyama C; Saito K; Kuki N; Matsuda M; Honma N; Ohnishi H; Matozaki T; Okada M; Nakagawa A J Mol Biol; 2008 Jan; 375(3):650-60. PubMed ID: 18045614 [TBL] [Abstract][Full Text] [Related]
16. [Role of CD47 in hematologic malignancies]. Su GH; Zhao YL Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1631-4. PubMed ID: 24370062 [TBL] [Abstract][Full Text] [Related]
17. SLAMF7 is critical for phagocytosis of haematopoietic tumour cells via Mac-1 integrin. Chen J; Zhong MC; Guo H; Davidson D; Mishel S; Lu Y; Rhee I; Pérez-Quintero LA; Zhang S; Cruz-Munoz ME; Wu N; Vinh DC; Sinha M; Calderon V; Lowell CA; Danska JS; Veillette A Nature; 2017 Apr; 544(7651):493-497. PubMed ID: 28424516 [TBL] [Abstract][Full Text] [Related]
18. Combination of CD47 and signal-regulatory protein-α constituting the "don't eat me signal" is a prognostic factor in diffuse large B-cell lymphoma. Kazama R; Miyoshi H; Takeuchi M; Miyawaki K; Nakashima K; Yoshida N; Kawamoto K; Yanagida E; Yamada K; Umeno T; Suzuki T; Kato K; Takizawa J; Seto M; Akashi K; Ohshima K Cancer Sci; 2020 Jul; 111(7):2608-2619. PubMed ID: 32342603 [TBL] [Abstract][Full Text] [Related]
19. Exosome-SIRPα, a CD47 blockade increases cancer cell phagocytosis. Koh E; Lee EJ; Nam GH; Hong Y; Cho E; Yang Y; Kim IS Biomaterials; 2017 Mar; 121():121-129. PubMed ID: 28086180 [TBL] [Abstract][Full Text] [Related]
20. Molecular Pathways: Activating T Cells after Cancer Cell Phagocytosis from Blockade of CD47 "Don't Eat Me" Signals. McCracken MN; Cha AC; Weissman IL Clin Cancer Res; 2015 Aug; 21(16):3597-601. PubMed ID: 26116271 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]